Cyclerion Therapeutics, Inc. (NASDAQ:CYCN – Get Rating) traded down 0.9% during mid-day trading on Wednesday . The stock traded as low as $4.25 and last traded at $4.31. 22,759 shares traded hands during trading, a decline of 5% from the average session volume of 23,926 shares. The stock had previously closed at $4.35.
Cyclerion Therapeutics Stock Performance
The firm’s 50-day simple moving average is $6.81 and its 200-day simple moving average is $10.92.
Cyclerion Therapeutics (NASDAQ:CYCN – Get Rating) last posted its quarterly earnings results on Wednesday, March 22nd. The company reported ($3.20) earnings per share (EPS) for the quarter. The business had revenue of $0.61 million for the quarter.
Institutional Trading of Cyclerion Therapeutics
Cyclerion Therapeutics Company Profile
Cyclerion Therapeutics, Inc is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate.
- Get a free copy of the StockNews.com research report on Cyclerion Therapeutics (CYCN)
- Big Lots Becomes A Stomach Churning Value Play
- The Melt-Up In Marvell Is On; But Don’t Chase It Higher
- Is Apple a Growth Stock or a Value Stock?
- Costco’s Earnings Call Reassure Economists, Recession Cancelled
- Hot Inflation, What It Means For The Summer Rally
Receive News & Ratings for Cyclerion Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclerion Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.